Drug interactions in cancer therapy (Q36516421)

14 August 2017

1 reference

title

Drug interactions in cancer therapy (English)

1 reference

14 August 2017

Charity D Scripture

1

1 reference

14 August 2017

William D Figg

series ordinal

2

1 reference

14 August 2017

language of work or name

English

0 references

publication date

1 July 2006

1 reference

14 August 2017

published in

Nature Reviews Cancer

1 reference

14 August 2017

volume

6

1 reference

14 August 2017

issue

7

1 reference

14 August 2017

page(s)

546-558

1 reference

https://scigraph.springernature.com/pub.10.1038/nrc1887

14 August 2017

exact match

0 references

cites work

Clinical-pharmacological strategies to assess drug interaction potential during drug development

1 reference

Effects of food on the clinical pharmacokinetics of anticancer agents: underlying mechanisms and implications for oral chemotherapy

21 January 2018

1 reference

Herbal remedies in the United States: potential adverse interactions with anticancer agents

21 January 2018

1 reference

Modulation of cytochrome P450 activity: implications for cancer therapy

21 January 2018

1 reference

Inheritance and drug response

21 January 2018

1 reference

Pharmacogenomics--drug disposition, drug targets, and side effects

21 January 2018

1 reference

Efficacy and safety of a specific inhibitor of the BCR-ABL tyrosine kinase in chronic myeloid leukemia

21 January 2018

1 reference

Efficacy and safety of imatinib mesylate in advanced gastrointestinal stromal tumors

21 January 2018

1 reference

Can food affect the bioavailability of chlorambucil in patients with haematological malignancies?

21 January 2018

1 reference

The gut as a barrier to drug absorption: combined role of cytochrome P450 3A and P-glycoprotein

21 January 2018

1 reference

Grapefruit juice and drugs. How significant is the interaction?

21 January 2018

1 reference

Inactivation of cytochrome P450 3A4 by bergamottin, a component of grapefruit juice

21 January 2018

1 reference

Exposure-dependent inhibition of intestinal and hepatic CYP3A4 in vivo by grapefruit juice

21 January 2018

1 reference

Role of P-glycoprotein in pharmacokinetics: clinical implications

21 January 2018

1 reference

Does inhibition of P-glycoprotein lead to drug-drug interactions?

21 January 2018

1 reference

Herbal modulation of P-glycoprotein

21 January 2018

1 reference

Dose-dependent increase of saquinavir bioavailability by the pharmaceutic aid cremophor EL

21 January 2018

1 reference

Pharmacokinetic and pharmaceutic interaction between digoxin and Cremophor RH40.

21 January 2018

1 reference

Reversal of multidrug resistance by surfactants

21 January 2018

1 reference

Role of formulation vehicles in taxane pharmacology

21 January 2018

1 reference

Mechanisms of resistance to anticancer drugs: the role of the polymorphic ABC transporters ABCB1 and ABCG2.

21 January 2018

1 reference

Functional interaction of intestinal CYP3A4 and P-glycoprotein

21 January 2018

1 reference

Changes in plasma protein binding have little clinical relevance

21 January 2018

1 reference

Pharmacokinetic-pharmacodynamic consequences and clinical relevance of cytochrome P450 3A4 inhibition

21 January 2018

1 reference

The human orphan nuclear receptor PXR is activated by compounds that regulate CYP3A4 gene expression and cause drug interactions

21 January 2018

1 reference

Identification of a human nuclear receptor defines a new signaling pathway for CYP3A induction

21 January 2018

1 reference

An orphan nuclear receptor activated by pregnanes defines a novel steroid signaling pathway

21 January 2018

1 reference

Role of orphan nuclear receptors in the regulation of drug-metabolising enzymes.

21 January 2018

1 reference

The repressed nuclear receptor CAR responds to phenobarbital in activating the human CYP2B6 gene

21 January 2018

1 reference

Drug-drug interactions in oncology: why are they important and can they be minimized?

21 January 2018

1 reference

Modification of the pharmacokinetics of high-dose cyclophosphamide and cisplatin by antiemetics

21 January 2018

1 reference

Pharmacokinetic interaction between ondansetron and cyclophosphamide during high-dose chemotherapy for breast cancer

21 January 2018

1 reference

Recommendations for the use of antiemetics: evidence-based, clinical practice guidelines. American Society of Clinical Oncology

21 January 2018

1 reference

The prevalence of complementary/alternative medicine in cancer: a systematic review

21 January 2018

1 reference

St John's wort-associated drug interactions: short-term inhibition and long-term induction?

21 January 2018

1 reference

The induction of cytochrome P450 3A5 (CYP3A5) in the human liver and intestine is mediated by the xenobiotic sensors pregnane X receptor (PXR) and constitutively activated receptor (CAR).

21 January 2018

1 reference

St. John's wort induces hepatic drug metabolism through activation of the pregnane X receptor

21 January 2018

1 reference

Effects of St. John's wort on irinotecan metabolism

21 January 2018

1 reference

Interactions between antiretrovirals and antineoplastic drug therapy.

21 January 2018

1 reference

Effect of St John's wort on imatinib mesylate pharmacokinetics

21 January 2018

1 reference

Pharmacokinetic interaction between ketoconazole and imatinib mesylate (Glivec) in healthy subjects

21 January 2018

1 reference

Genetic polymorphisms of cytochrome P450 2D6 (CYP2D6): clinical consequences, evolutionary aspects and functional diversity

21 January 2018

1 reference

Comprehensive evaluation of tamoxifen sequential biotransformation by the human cytochrome P450 system in vitro: prominent roles for CYP3A and CYP2D6.

21 January 2018

1 reference

21 January 2018

1 reference

CYP2D6 genotype, antidepressant use, and tamoxifen metabolism during adjuvant breast cancer treatment

21 January 2018

1 reference

Potential role of pharmacogenomics in reducing adverse drug reactions: a systematic review

21 January 2018

1 reference

Metabolism and pharmacokinetics of oxazaphosphorines

21 January 2018

1 reference

Pharmacogenetics of irinotecan toxicity

21 January 2018

1 reference

A phase II trial of gefitinib with 5-fluorouracil, leucovorin, and irinotecan in patients with colorectal cancer

21 January 2018

1 reference

High-affinity interaction of tyrosine kinase inhibitors with the ABCG2 multidrug transporter

21 January 2018

1 reference

Carboxylesterase-mediated sensitization of human tumor cells to CPT-11 cannot override ABCG2-mediated drug resistance

21 January 2018

1 reference

Organic anion-transporting polypeptide (OATP) transporter family and drug disposition

21 January 2018

1 reference

Pharmacogenomics of the OATP and OAT families

21 January 2018

1 reference

The organic anion transporter (OATP) family.

21 January 2018

1 reference

Characterization of methotrexate transport and its drug interactions with human organic anion transporters

21 January 2018

1 reference

Methotrexate and nonsteroidal antiinflammatory drug interactions

21 January 2018

1 reference

Intermittent high dose oral methotrexate therapy in psoriasis

21 January 2018

1 reference

Leucovorin enhancement of the effects of the fluoropyrimidines on thymidylate synthase

21 January 2018

1 reference

Randomized phase III study of high-dose fluorouracil given as a weekly 24-hour infusion with or without leucovorin versus bolus fluorouracil plus leucovorin in advanced colorectal cancer: European organization of Research and Treatment of Cancer Gas

21 January 2018

1 reference

Reduction of toxicity of interleukin-2 and lymphokine-activated killer cells in humans by the administration of corticosteroids

21 January 2018

1 reference

The influence of aminoglycosides on the nephrotoxicity of cis-diamminedichloroplatinum in cancer patients

21 January 2018

1 reference

Effects of cisplatin and amphotericin B on DNA adduct formation and toxicity in malignant glioma and normal tissues in rat.

21 January 2018

1 reference

Vinorelbine-induced acute reversible peripheral neuropathy in a patient with ovarian carcinoma pretreated with carboplatin and paclitaxel

21 January 2018

1 reference

Severe neurotoxicity from vinorelbine-paclitaxel combinations

21 January 2018

1 reference

Drug interactions with the taxanes: clinical implications

21 January 2018

1 reference

Carboplatin and paclitaxel in ovarian carcinoma: a phase I study of the Gynecologic Oncology Group

21 January 2018

1 reference

Phase I trial, including pharmacokinetic and pharmacodynamic correlations, of combination paclitaxel and carboplatin in patients with metastatic non-small-cell lung cancer

21 January 2018

1 reference

Taxane/anthracycline combinations: setting a new standard in breast cancer?

21 January 2018

1 reference

Sequence-dependent alteration of doxorubicin pharmacokinetics by paclitaxel in a phase I study of paclitaxel and doxorubicin in patients with metastatic breast cancer

21 January 2018

1 reference

Modulation of irinotecan metabolism by ketoconazole

21 January 2018

1 reference

Can food influence the absorption of methotrexate in children with acute lymphoblastic leukaemia?

21 January 2018

1 reference

Oral topotecan: bioavailablity and effect of food co-administration

21 January 2018

1 reference

Determination of altretamine in human plasma with high-performance liquid chromatography.

21 January 2018

1 reference

Pharmacokinetics and tolerability of the orally active selective epidermal growth factor receptor tyrosine kinase inhibitor ZD1839 in healthy volunteers

21 January 2018

1 reference

The effect of food on oral melphalan absorption.

21 January 2018

1 reference

6-Thioguanine in children with acute lymphoblastic leukaemia: influence of food on parent drug pharmacokinetics and 6-thioguanine nucleotide concentrations

21 January 2018

1 reference

Pharmacokinetics of all-trans-retinoic acid in Japanese patients with acute promyelocytic leukemia.

21 January 2018

1 reference

The effect of food and concurrent chemotherapy on the bioavailability of oral etoposide.

21 January 2018

1 reference

Oral mercaptopurine in childhood leukemia: influence of food intake on bioavailability.

21 January 2018

1 reference

Phase I dose-escalation and pharmacokinetic study of temozolomide (SCH 52365) for refractory or relapsing malignancies

21 January 2018

1 reference

In vitro evaluation of cytochrome P450-mediated drug interactions between cytarabine, idarubicin, itraconazole and caspofungin

21 January 2018

1 reference

The role of human cytochrome P450 enzymes in the metabolism of anticancer agents: implications for drug interactions

21 January 2018

1 reference

Inhibition of cytochromes P450 by antifungal imidazole derivatives

21 January 2018

1 reference

Effect of tamoxifen on the enzymatic activity of human cytochrome CYP2B6.

21 January 2018

1 reference

A monohydroxylated metabolite of tamoxifen with potent antioestrogenic activity

21 January 2018

1 reference

A phase I trial of pharmacologic modulation of irinotecan with cyclosporine and phenobarbital

21 January 2018

1 reference

Effects of ketoconazole on glucuronidation by UDP-glucuronosyltransferase enzymes

21 January 2018

1 reference

Irinotecan therapy in adults with recurrent or progressive malignant glioma

21 January 2018

1 reference

Impairment of estramustine phosphate absorption by concurrent intake of milk and food

21 January 2018

1 reference

Inhibition and induction of cytochrome P450 and the clinical implications

31 March 2020

1 reference

St John's Wort induces intestinal P-glycoprotein/MDR1 and intestinal and hepatic CYP3A4

31 March 2020

1 reference

Glucuronidation of 7-ethyl-10-hydroxycamptothecin (SN-38) by the human UDP-glucuronosyltransferases encoded at the UGT1 locus

31 March 2020

1 reference

Potential interaction of antiretroviral therapy with paclitaxel in patients with AIDS-related Kaposi's sarcoma

31 March 2020

1 reference

Variable contribution of cytochromes P450 2D6, 2C9 and 3A4 to the 4-hydroxylation of tamoxifen by human liver microsomes

31 March 2020

1 reference

Pharmacokinetics of paclitaxel and carboplatin in a dose-escalating and dose-sequencing study in patients with non-small-cell lung cancer. The European Cancer Centre

31 March 2020

1 reference

Sequence effect of epirubicin and paclitaxel treatment on pharmacokinetics and toxicity

31 March 2020

1 reference

Adverse effect of anticonvulsants on efficacy of chemotherapy for acute lymphoblastic leukaemia

31 March 2020

1 reference

Evaluation of aminoglycoside disposition in patients previously treated with cisplatin

31 March 2020

1 reference

inferred from DOI database lookup

7 January 2021

based on heuristic

Identifiers

DOI

10.1038/NRC1887

1 reference

14 August 2017

1 reference